Please assess the completion status of the following clinical trial:

Trial Title: Electroacupuncture for Diminished Ovarian Reserve

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age younger than 40 yr~* 10IU/L ≤ FSH ≤ 40IU/L~* Volunteer to join the research and give the informed consent~Exclusion Criteria:~* A history of ovariectomy, receiving cytotoxic chemotherapy or irradiation~* Reproductive system infection or tumor~* Autoimmune disease~* Amenorrhea due to reproduction abnormality or pregnancy~* Patients can not adhere to treatment due to personal situation~* Patients have taken immunosuppressive agents in past 6 months~* receive treatment for less than 1 week before withdrawal

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- EA group (Type: EXPERIMENTAL): Patients choose this group will receive EA as a combination. Beside of EA, participants could receive oral medicine as the same as that of the drug group. The EA regimen has two point formulae, i.e. A (BL33) and B (ST25, EX-CA1 and RN4). The two formulae will be used alternatively. One session will last for 20 minutes, 5 sessions per week for the first 4 weeks and 3 sessions per week later (44 sessions in all).
- drug group (Type: ACTIVE_COMPARATOR): Hormone replacement therapy (HRT), DHEA and herb decoction are allowed to be used for this group. Treatment course is not fixed. Immunosuppressive agents are not allowed.

Based on this trial design, predict the completion outcome and termination type (if applicable).